The award will help Gokel and his group, Upaya Pharmaceuticals, progress their antibiotic resistance technology along the path toward commercialization.
The award will help Gokel and his group, Upaya Pharmaceuticals, progress their antibiotic resistance technology along the path toward commercialization.
The award will help Gokel and his group, Upaya Pharmaceuticals, progress their antibiotic resistance technology along the path toward commercialization.
The award will help Gokel and his group, Upaya Pharmaceuticals, progress their antibiotic resistance technology along the path toward commercialization.
Lohmann earned a PhD in biology with an emphasis in ecology, evolution and systematics from UMSL in 2003 and had support from the Whitney R. Harris World Ecology while pursuing her degree.